Evidence map›Paper›PMID 42490118›Full record

Trial reportJAMA otolaryngology-- head & neck surgery2026

Mechanisms Underlying an Enhanced Navigation-Based Intervention to Improve Timely Adjuvant Therapy: A Secondary Analysis of the NDURE Randomized Clinical Trial.

Maya N Elhage, Emily Kistner-Griffin, Reid DeMass, Bhisham S Chera, Katherine R Sterba, Chanita Hughes Halbert, Elizabeth G Hill, Brian Nussenbaum, Anthony J Alberg, Megan T Nguyen and 21 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA otolaryngology-- head & neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04030130 (Parallel-Group, Randomized-Controlled Trial of Navigation Vs Usual Care for The Management of Delays and Racial Disparities Starting Adjuvant Therapy in Adults With Surgically-Managed, Locally Advanced HNSCC), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04030130 nacompletednot on this map

Parallel-Group, Randomized-Controlled Trial of Navigation Vs Usual Care for The Management of Delays and Racial Disparities Starting Adjuvant Therapy in Adults With Surgically-Managed, Locally Advanced HNSCC (NDURE 2.0)

TypeinterventionalSponsorMedical University of South CarolinaRan2020 to 2024Enrolled176ConditionsSquamous Cell Carcinoma of Head and NeckArmsNDURE
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Maya N ElhageDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Emily Kistner-GriffinDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Reid DeMassDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Bhisham S CheraHollings Cancer Center, Medical University of South Carolina, Charleston.
Katherine R SterbaDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Chanita Hughes HalbertDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Elizabeth G HillDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Brian NussenbaumAmerican Board of Otolaryngology-Head and Neck Surgery, Houston, Texas.
Anthony J AlbergDepartment of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia.
Megan T NguyenDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Jason G NewmanDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
W Greer AlbergottiDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Alexandra E KejnerDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Judith M SkonerDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Dauren AdilbayDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Michael BobianDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Jennifer L HarperHollings Cancer Center, Medical University of South Carolina, Charleston.
John KaczmarHollings Cancer Center, Medical University of South Carolina, Charleston.
Savannah A ZimmermanHollings Cancer Center, Medical University of South Carolina, Charleston.
Stacy StewartHollings Cancer Center, Medical University of South Carolina, Charleston.
Taylor McLeodDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Vlad C SandulacheBobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
David J HermandezBobby R. Alford Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Ryan S JacksonDepartment of Otolaryngology-Head and Neck Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri.
Sidharth V PuramDepartment of Otolaryngology-Head and Neck Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri.
Russel KahmkeDepartment of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina.
Nosayaba Osazuwa-PetersDepartment of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina.
Gail JacksonHead and Neck Cancer Alliance, Charleston, South Carolina.
Garrett T WaspSection of Oncology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Sue S YomDepartment of Radiation Oncology, University of California, San Francisco.
Evan M GraboyesDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck CancerR01CA282165 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Evan Michael Graboyes · 2023 to 2026
$2.8M
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck CancerK08CA237858 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRABOYES, EVAN MICHAEL · 2019 to 2023
$1.3M
NCATS NIH HHS UL1 TR000062NCI NIH HHS K08 CA237858NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA282165
6 · The paper itself

Abstract

Importance: Initiation of postoperative radiation therapy (PORT) within 6 weeks of surgery is part of National Comprehensive Cancer Network guidelines for head and neck squamous cell carcinoma (HNSCC), yet more than 50% of patients experience a delay. In a randomized clinical trial of patients with locally advanced HNSCC undergoing surgery, Navigation for Disparities and Untimely Radiation Therapy (NDURE), an enhanced navigation-based intervention that targets PORT-related care steps, improved timely PORT relative to usual care (UC) navigation. Objectives: To examine the mechanisms by which NDURE improved timely PORT relative to UC navigation among patients with HNSCC. Design, Setting, and Participants: This randomized clinical trial was conducted at a single US academic medical center and enrolled adults with locally advanced HNSCC undergoing surgery and PORT. Data were collected from May 2020 to January 2024, and data were analyzed from May 2025 to January 2026. Main Outcomes and Measures: The primary end point was initiation of PORT within 6 weeks of surgery. Five PORT-related care steps were evaluated as mediators: (1) preoperative radiation oncology consultation, (2) preoperative dental evaluation, (3) timely postoperative radiation oncology evaluation (within 21 days of surgery), (4) timely computed tomography (CT) simulation (within 7 days after the radiation oncology appointment), and (5) timely radiation planning (CT simulation to PORT start within 14 days). Causal mediation analysis was performed to determine the effect of the PORT-related care steps, individually and as a group, on timely PORT. Results: Of 145 included patients, 51 (35.2%) were female and 94 (64.8%) were male; 30 (20.7%) were Black and 115 (79.3%) were White; and the median (IQR) age was 63.0 (54.0-69.0) years. A total of 67 patients were randomized to NDURE and 78 to UC. NDURE improved preoperative radiation oncology consultation (odds ratio [OR], 4.9; 95% CI, 2.3-10.3), preoperative dental evaluation and extractions (OR, 27.6; 95% CI, 3.6-213.0), timely postoperative radiation oncology evaluation (OR, 5.0; 95% CI, 2.4-10.7), and timely radiation planning (OR, 2.1; 95% CI, 1.1-4.2). Timely postoperative radiation oncology evaluation mediated 24% (95% CI, 8-65) and completion of more than half of the PORT-related care steps mediated 53% (95% CI, 28-95) of the effect of NDURE on improving timely PORT relative to UC. Conclusions and Relevance: In this secondary analysis of a randomized clinical trial, NDURE improved timely PORT relative to UC primarily by enhancing early postoperative evaluation by radiation oncology and completion of a greater number of PORT-related care steps. PORT-related care steps, including preoperative evaluation by radiation oncology, preoperative dental evaluation, timely postoperative radiation oncology evaluation, timely CT simulation, and timely radiation planning, are important intervention targets to improve timely PORT. Trial Registration: ClinicalTrials.gov Identifier: NCT04030130.

Indexed as

Head and Neck NeoplasmsPatient NavigationSquamous Cell Carcinoma of Head and NeckAgedFemaleHumansMaleMiddle AgedRadiotherapy, Adjuvant

Identifiers

PMID42490118
PMCPMC13397119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.